12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Thursday's intraday session, several healthcare stocks experienced significant movements. Orchard Therapeutics, Histogen, Clene, Orgenesis, Omega Therapeutics, and Matinas BioPharma Hldgs saw their shares increase by 96.5%, 47.17%, 21.0%, 19.98%, 19.4%, and 15.85% respectively. On the other hand, MaxCyte, Longeveron, Viracta Therapeutics, Nanobiotix, SenesTech, and Renalytix saw their shares decline by 22.6%, 17.93%, 17.39%, 17.14%, 16.29%, and 16.11% respectively.
October 05, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Clene stock moved upwards by 21.0% to $0.6.
The significant increase in Clene's share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Histogen shares moved upwards by 47.17% to $0.75.
The significant increase in Histogen's share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Matinas BioPharma Hldgs shares increased by 15.85% to $0.14.
The significant increase in Matinas BioPharma Hldgs' share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Omega Therapeutics shares increased by 19.4% to $2.06.
The significant increase in Omega Therapeutics' share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Orgenesis stock increased by 19.98% to $0.78.
The significant increase in Orgenesis' share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Orchard Therapeutics shares increased by 96.5% to $15.99.
The significant increase in Orchard Therapeutics' share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Longeveron stock decreased by 17.93% to $2.06.
The significant decrease in Longeveron's share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
MaxCyte shares declined by 22.6% to $2.53.
The significant decrease in MaxCyte's share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Nanobiotix stock decreased by 17.14% to $7.45.
The significant decrease in Nanobiotix's share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Renalytix stock declined by 16.11% to $1.25.
The significant decrease in Renalytix's share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
SenesTech stock decreased by 16.29% to $0.37.
The significant decrease in SenesTech's share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Viracta Therapeutics stock declined by 17.39% to $0.76.
The significant decrease in Viracta Therapeutics' share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100